Adriana Olar to Aged
This is a "connection" page, showing publications Adriana Olar has written about Aged.
Connection Strength
0.325
-
Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma. Acta Neuropathol. 2017 03; 133(3):431-444.
Score: 0.048
-
Central nervous system involvement by myeloid sarcoma: a report of 12 cases and review of the literature. Clin Neuropathol. 2016 Sep-Oct; 35(5):314-25.
Score: 0.046
-
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. Acta Neuropathol. 2015 Apr; 129(4):585-96.
Score: 0.042
-
Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma. Brain Pathol. 2015 May; 25(3):266-75.
Score: 0.041
-
Seizures in Patients With Metastatic Brain Tumors: Prevalence, Clinical Characteristics, and Features on EEG. J Clin Neurophysiol. 2021 Mar 01; 38(2):143-148.
Score: 0.016
-
Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumors. Neuro Oncol. 2019 09 06; 21(9):1164-1174.
Score: 0.014
-
Seizures in patents with primary central nervous system lymphoma: Prevalence and associated features. J Neurol Sci. 2019 May 15; 400:34-38.
Score: 0.014
-
DNA methylation-based reclassification of olfactory neuroblastoma. Acta Neuropathol. 2018 08; 136(2):255-271.
Score: 0.013
-
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathol. 2018 08; 136(2):273-291.
Score: 0.013
-
DNA methylation-based classification of central nervous system tumours. Nature. 2018 03 22; 555(7697):469-474.
Score: 0.013
-
Ependymomas arising outside of the central nervous system: A case series and literature review. J Clin Neurosci. 2018 Jan; 47:202-207.
Score: 0.012
-
Sarcoma Brain Metastases: 28?Years of Experience at a Single Institution. Ann Surg Oncol. 2016 12; 23(Suppl 5):962-967.
Score: 0.012
-
TERT Promoter Mutations and Risk of Recurrence in Meningioma. J Natl Cancer Inst. 2016 May; 108(5).
Score: 0.011
-
Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol. 2015 Nov; 125(2):401-10.
Score: 0.011
-
Corticosteroid sensitivity in gliomatosis cerebri delays diagnosis. Pract Neurol. 2015 Aug; 15(4):309-11.
Score: 0.011
-
Lambrolizumab induced central nervous system (CNS) toxicity. J Neurol Sci. 2014 Sep 15; 344(1-2):229-31.
Score: 0.010